Jeremy A. Schwartzentruber
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Predicting expression-altering promoter mutations with deep learning.
Journal: Science (New York, N.Y.)
Published: May 29, 2025
Estimation and mapping of the missing heritability of human phenotypes.
Journal: Nature
Published: January 12, 2025
Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery.
Journal: Nucleic acids research
Published: September 13, 2024
Artificial intelligence for dementia genetics and omics.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 05, 2023
The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.
Journal: Nucleic acids research
Published: September 15, 2022
Correction to: Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia.
Journal: Orphanet journal of rare diseases
Published: March 30, 2022
Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.
Journal: EBioMedicine
Published: March 08, 2022
Screening for functional regulatory variants in open chromatin using GenIE-ATAC.
Journal: Nucleic acids research
Published: February 09, 2022
Mapping interindividual dynamics of innate immune response at single-cell resolution.
Journal: Nature genetics
Published: August 28, 2021
Last Updated: 09/26/2026